APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Josamycin Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Josamycin Tablets Industry Growth and Trends Forecast to 2032

Report ID 174005420126 December 202590 pages

Choose your research edition.

Industry ResearchJosamycin Tablets Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Josamycin Tablets Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Josamycin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Josamycin Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Josamycin Tablets Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Josamycin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Josamycin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Josamycin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Josamycin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Josamycin Tablets include Shanghai Sine Pharmaceutical, Harbin Pharmaceutical Group, Guilin Nantang Pharmaceutical, Guangzhou Baiyunshan Guanghua Pharmaceutical, Astellas Pharma and CSPC OUYI PHARMACEUTICAL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Josamycin Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Josamycin Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Josamycin Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Josamycin Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Josamycin Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Josamycin Tablets Market by Company

Shanghai Sine Pharmaceutical

Harbin Pharmaceutical Group

Guilin Nantang Pharmaceutical

Guangzhou Baiyunshan Guanghua Pharmaceutical

Astellas Pharma

CSPC OUYI PHARMACEUTICAL

Josamycin Tablets Segment by Type

200mg

50mg

Josamycin Tablets Segment by Application

Hospital

Clinic

Others

Josamycin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Josamycin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Josamycin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Josamycin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Josamycin Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Josamycin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200mg Table 2. Major Company of 50mg Table 3. Global Josamycin Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Josamycin Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Josamycin Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Josamycin Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Josamycin Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Josamycin Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Josamycin Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Josamycin Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Josamycin Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Josamycin Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Josamycin Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Josamycin Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Josamycin Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Josamycin Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Josamycin Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Josamycin Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Josamycin Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Josamycin Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Josamycin Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Josamycin Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Josamycin Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Josamycin Tablets Industry Trends Table 25. Josamycin Tablets Industry Drivers Table 26. Josamycin Tablets Industry Opportunities and Challenges Table 27. Josamycin Tablets Industry Restraints Table 28. Global Josamycin Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Josamycin Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Josamycin Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Josamycin Tablets Sales Share by Company (2021-2026) Table 32. Global Josamycin Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Josamycin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Josamycin Tablets Major Company Production Sites and Headquarters Table 35. Global Josamycin Tablets Company, Product Type & Application Table 36. Global Josamycin Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Josamycin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Josamycin Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Josamycin Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Josamycin Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Josamycin Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Josamycin Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Josamycin Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Josamycin Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Josamycin Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Josamycin Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Josamycin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Josamycin Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Josamycin Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Josamycin Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Josamycin Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Josamycin Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Josamycin Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Josamycin Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Josamycin Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Josamycin Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Josamycin Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Josamycin Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Josamycin Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Josamycin Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Josamycin Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Josamycin Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Josamycin Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Josamycin Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Josamycin Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Josamycin Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Josamycin Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Josamycin Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Sine Pharmaceutical Company Information Table 72. Shanghai Sine Pharmaceutical Business Overview Table 73. Shanghai Sine Pharmaceutical Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Shanghai Sine Pharmaceutical Josamycin Tablets Product Portfolio Table 75. Shanghai Sine Pharmaceutical Recent Development Table 76. Harbin Pharmaceutical Group Company Information Table 77. Harbin Pharmaceutical Group Business Overview Table 78. Harbin Pharmaceutical Group Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Harbin Pharmaceutical Group Josamycin Tablets Product Portfolio Table 80. Harbin Pharmaceutical Group Recent Development Table 81. Guilin Nantang Pharmaceutical Company Information Table 82. Guilin Nantang Pharmaceutical Business Overview Table 83. Guilin Nantang Pharmaceutical Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guilin Nantang Pharmaceutical Josamycin Tablets Product Portfolio Table 85. Guilin Nantang Pharmaceutical Recent Development Table 86. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 87. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 88. Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Product Portfolio Table 90. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 91. Astellas Pharma Company Information Table 92. Astellas Pharma Business Overview Table 93. Astellas Pharma Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Astellas Pharma Josamycin Tablets Product Portfolio Table 95. Astellas Pharma Recent Development Table 96. CSPC OUYI PHARMACEUTICAL Company Information Table 97. CSPC OUYI PHARMACEUTICAL Business Overview Table 98. CSPC OUYI PHARMACEUTICAL Josamycin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. CSPC OUYI PHARMACEUTICAL Josamycin Tablets Product Portfolio Table 100. CSPC OUYI PHARMACEUTICAL Recent Development Table 101. North America Josamycin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Josamycin Tablets Sales by Country (2021-2026) & (K Units) Table 103. North America Josamycin Tablets Sales Market Share by Country (2021-2026) Table 104. North America Josamycin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Josamycin Tablets Sales Market Share Forecast by Country (2027-2032) Table 106. North America Josamycin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Josamycin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Josamycin Tablets Market Share by Country (2021-2026) Table 109. North America Josamycin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Josamycin Tablets Market Share Forecast by Country (2027-2032) Table 111. Europe Josamycin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Josamycin Tablets Sales by Country (2021-2026) & (K Units) Table 113. Europe Josamycin Tablets Sales Market Share by Country (2021-2026) Table 114. Europe Josamycin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Josamycin Tablets Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Josamycin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Josamycin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Josamycin Tablets Market Share by Country (2021-2026) Table 119. Europe Josamycin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Josamycin Tablets Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Josamycin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Josamycin Tablets Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Josamycin Tablets Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Josamycin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Josamycin Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Josamycin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Josamycin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Josamycin Tablets Market Share by Country (2021-2026) Table 129. Asia-Pacific Josamycin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Josamycin Tablets Market Share Forecast by Country (2027-2032) Table 131. Latin America Josamycin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Josamycin Tablets Sales by Country (2021-2026) & (K Units) Table 133. Latin America Josamycin Tablets Sales Market Share by Country (2021-2026) Table 134. Latin America Josamycin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Josamycin Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Josamycin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Josamycin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Josamycin Tablets Market Share by Country (2021-2026) Table 139. Latin America Josamycin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Josamycin Tablets Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Josamycin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Josamycin Tablets Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Josamycin Tablets Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Josamycin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Josamycin Tablets Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Josamycin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Josamycin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Josamycin Tablets Market Share by Country (2021-2026) Table 149. Middle East and Africa Josamycin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Josamycin Tablets Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Josamycin Tablets Distributors List Table 154. Josamycin Tablets Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Josamycin Tablets Image Figure 2. Global Josamycin Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Josamycin Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Josamycin Tablets Sales (2021-2032) & (K Units) Figure 5. 200mg Image Figure 6. Global 200mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 50mg Image Figure 8. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Josamycin Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Josamycin Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Josamycin Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Josamycin Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Josamycin Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Josamycin Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Josamycin Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Josamycin Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Josamycin Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Josamycin Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Josamycin Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Josamycin Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Josamycin Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Josamycin Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Josamycin Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Josamycin Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Josamycin Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Josamycin Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Josamycin Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Josamycin Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Josamycin Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Josamycin Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Josamycin Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Josamycin Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Josamycin Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Josamycin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Josamycin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Josamycin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Josamycin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Josamycin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Josamycin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Josamycin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Josamycin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Josamycin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Josamycin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Josamycin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Josamycin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Josamycin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Josamycin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Josamycin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Josamycin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Josamycin Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Josamycin Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Shanghai Sine Pharmaceutical
  • Harbin Pharmaceutical Group
  • Guilin Nantang Pharmaceutical
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Astellas Pharma
  • CSPC OUYI PHARMACEUTICAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Josamycin Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Josamycin Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Josamycin Tablets Market by Type
  6. 1.3.1 200mg
  7. 1.3.2 50mg
  8. 1.4 Global Josamycin Tablets Market Size by Type
  9. 1.4.1 Global Josamycin Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Josamycin Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Josamycin Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Josamycin Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Josamycin Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Josamycin Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Josamycin Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Josamycin Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Josamycin Tablets Industry Trends
  2. 2.2 Josamycin Tablets Industry Drivers
  3. 2.3 Josamycin Tablets Industry Opportunities and Challenges
  4. 2.4 Josamycin Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Josamycin Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Josamycin Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Josamycin Tablets Price (2021-2026)
  4. 3.4 Global Josamycin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Josamycin Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Josamycin Tablets Company, Product Type & Application
  7. 3.7 Global Josamycin Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Josamycin Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Josamycin Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Josamycin Tablets Tier 1, Tier 2, and Tier 3
4 Josamycin Tablets Regional Status and Outlook
  1. 4.1 Global Josamycin Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Josamycin Tablets Historic Market Size by Region
  3. 4.2.1 Global Josamycin Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Josamycin Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Josamycin Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Josamycin Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Josamycin Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Josamycin Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Josamycin Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Josamycin Tablets by Application
  1. 5.1 Josamycin Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Josamycin Tablets Market Size by Application
  6. 5.2.1 Global Josamycin Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Josamycin Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Josamycin Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Josamycin Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Josamycin Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Josamycin Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Josamycin Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Josamycin Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Sine Pharmaceutical
  2. 6.1.1 Shanghai Sine Pharmaceutical Company Information
  3. 6.1.2 Shanghai Sine Pharmaceutical Business Overview
  4. 6.1.3 Shanghai Sine Pharmaceutical Josamycin Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Sine Pharmaceutical Josamycin Tablets Product Portfolio
  6. 6.1.5 Shanghai Sine Pharmaceutical Recent Developments
  7. 6.2 Harbin Pharmaceutical Group
  8. 6.2.1 Harbin Pharmaceutical Group Company Information
  9. 6.2.2 Harbin Pharmaceutical Group Business Overview
  10. 6.2.3 Harbin Pharmaceutical Group Josamycin Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Harbin Pharmaceutical Group Josamycin Tablets Product Portfolio
  12. 6.2.5 Harbin Pharmaceutical Group Recent Developments
  13. 6.3 Guilin Nantang Pharmaceutical
  14. 6.3.1 Guilin Nantang Pharmaceutical Company Information
  15. 6.3.2 Guilin Nantang Pharmaceutical Business Overview
  16. 6.3.3 Guilin Nantang Pharmaceutical Josamycin Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guilin Nantang Pharmaceutical Josamycin Tablets Product Portfolio
  18. 6.3.5 Guilin Nantang Pharmaceutical Recent Developments
  19. 6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical
  20. 6.4.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  21. 6.4.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  22. 6.4.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Josamycin Tablets Product Portfolio
  24. 6.4.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  25. 6.5 Astellas Pharma
  26. 6.5.1 Astellas Pharma Company Information
  27. 6.5.2 Astellas Pharma Business Overview
  28. 6.5.3 Astellas Pharma Josamycin Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Astellas Pharma Josamycin Tablets Product Portfolio
  30. 6.5.5 Astellas Pharma Recent Developments
  31. 6.6 CSPC OUYI PHARMACEUTICAL
  32. 6.6.1 CSPC OUYI PHARMACEUTICAL Company Information
  33. 6.6.2 CSPC OUYI PHARMACEUTICAL Business Overview
  34. 6.6.3 CSPC OUYI PHARMACEUTICAL Josamycin Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSPC OUYI PHARMACEUTICAL Josamycin Tablets Product Portfolio
  36. 6.6.5 CSPC OUYI PHARMACEUTICAL Recent Developments
7 North America by Country
  1. 7.1 North America Josamycin Tablets Sales by Country
  2. 7.1.1 North America Josamycin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Josamycin Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Josamycin Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Josamycin Tablets Market Size by Country
  6. 7.2.1 North America Josamycin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Josamycin Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Josamycin Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Josamycin Tablets Sales by Country
  2. 8.1.1 Europe Josamycin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Josamycin Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Josamycin Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Josamycin Tablets Market Size by Country
  6. 8.2.1 Europe Josamycin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Josamycin Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Josamycin Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Josamycin Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Josamycin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Josamycin Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Josamycin Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Josamycin Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Josamycin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Josamycin Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Josamycin Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Josamycin Tablets Sales by Country
  2. 10.1.1 South America Josamycin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Josamycin Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Josamycin Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Josamycin Tablets Market Size by Country
  6. 10.2.1 South America Josamycin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Josamycin Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Josamycin Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Josamycin Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Josamycin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Josamycin Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Josamycin Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Josamycin Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Josamycin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Josamycin Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Josamycin Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Josamycin Tablets Value Chain Analysis
  2. 12.1.1 Josamycin Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Josamycin Tablets Production Mode & Process
  7. 12.2 Josamycin Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Josamycin Tablets Distributors
  10. 12.2.3 Josamycin Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst